| 1 |
pancreatic ductal adenocarcinoma
(8685 times)
|
Neoplasms
(3661 times)
|
OS (722 times)
EMT (282 times)
CI (247 times)
|
1996 Neurotrophin-Trk receptor interactions in neoplasia: a possible role in interstitial and perineural invasion in ductal pancreatic cancer.
|
| 2 |
poly(diallyldimethylammonium chloride)
(19 times)
|
Chemistry
(11 times)
|
PEM (5 times)
PSS (5 times)
SPS (5 times)
|
2004 Dip-pen nanolithography with poly(diallyl dimethyl ammonium) chloride.
|
| 3 |
pancreatic ductal cancer
(6 times)
|
Neoplasms
(3 times)
|
CE-EUS (1 time)
ctDNA (1 time)
EMT (1 time)
|
2017 [Bit1 mediates the malignant behaviors in pancreatic cancer and its potential clinical significance].
|
| 4 |
primary duodenal adenocarcinoma
(4 times)
|
Gastroenterology
(3 times)
|
PD (3 times)
SR (3 times)
CI (1 time)
|
2009 The surgical treatment and outcome for primary duodenal adenocarcinoma.
|
| 5 |
patients with ductal adenocarcinoma of the pancreas
(3 times)
|
Bioengineering
(1 time)
|
CA19-9 (1 time)
CEA (1 time)
GEO (1 time)
|
2008 The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death.
|
| 6 |
poor differentiated adenocarcinoma
(3 times)
|
Neoplasms
(2 times)
|
AdHGD (1 time)
MAC (1 time)
MDAC (1 time)
|
1988 [Pathologic study on the treatment-effect of hematoporphyrin derivative in carcinoma of the gastric cardia].
|
| 7 |
BACKGROUNDPancreatic ductal adenocarcinoma
(2 times)
|
Biomedical Research
(1 time)
|
alpha-SMA (1 time)
CK-19 (1 time)
OBP (1 time)
|
2022 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma.
|
| 8 |
pancreatic ductal
(2 times)
|
Medicine
(1 time)
|
EVs (1 time)
|
2015 CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
|
| 9 |
pancreatic head
(2 times)
|
Radiology
(1 time)
|
CT (1 time)
|
2019 Correlation between appearance of the retroportal fat plane at preoperative CT and pathology findings in resected adenocarcinoma of the pancreatic head.
|
| 10 |
Placenta Derived Adherent Cell
(2 times)
|
Wounds and Injuries
(1 time)
|
BrdU (1 time)
GAGs (1 time)
MCAO (1 time)
|
2008 Placenta Derived Adherent Cell (PDAC) Interaction and Response on Extracellular Matrix Isolated from Human Placenta t.
|
| 11 |
poly(dimethyldiallylammonium chloride)
(2 times)
|
Chemistry
(1 time)
|
DOPC (1 time)
FRAPP (1 time)
LbL (1 time)
|
2006 Arrays of lipid bilayers and liposomes on patterned polyelectrolyte templates.
|
| 12 |
BIOT-NFL-PEG-AuNPs to target the destruction of pancreatic cancer cells
(1 time)
|
|
BIOT-NFL (1 time)
|
2022 NFL-TBS.40-63 Peptide Gold Complex Nanovector: A Novel Therapeutic Approach to Increase Anticancer Activity by Breakdown of Microtubules in Pancreatic Adenocarcinoma (PDAC).
|
| 13 |
destroying pancreatic cancer cells
(1 time)
|
|
BIOT-NFL (1 time)
CPP (1 time)
DLS (1 time)
|
2022 Cell penetrating peptide (CPP) gold(iii) - complex - bioconjugates: from chemical design to interaction with cancer cells for nanomedicine applications.
|
| 14 |
pancreas adenocarcinoma
(1 time)
|
General Surgery
(1 time)
|
NAT (1 time)
UR (1 time)
|
2020 Neoadjuvant therapy versus upfront surgery for early-stage left-sided pancreatic adenocarcinoma: A propensity-matched analysis from a national cohort of distal pancreatectomies.
|
| 15 |
pancreas and are of the ductal adenocarcinoma histological subtype
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2016 Molecular Pathogenesis of Pancreatic Cancer.
|
| 16 |
pancreas and pancreatic cancer
(1 time)
|
Neoplasms
(1 time)
|
MACE (1 time)
miRNAs (1 time)
|
2015 Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
|
| 17 |
pancreatic adenocarcinoma cell lines
(1 time)
|
Cell Physiological Processes
(1 time)
|
AMPK (1 time)
BBR (1 time)
|
2019 Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells.
|
| 18 |
pancreatic cells including ductal adenocarcinoma
(1 time)
|
General Surgery
(1 time)
|
---
|
2015 Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
|
| 19 |
pancreatic ductal system
(1 time)
|
Neoplasms
(1 time)
|
---
|
2017 MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma.
|
| 20 |
pancreatic lesions, by one in ductal adenocarcinoma
(1 time)
|
General Surgery
(1 time)
|
LOS (1 time)
ODP (1 time)
POPF (1 time)
|
2016 Laparoscopic distal pancreatectomy: many meta-analyses, few certainties.
|
| 21 |
pancreatic tumors are invasive ductal adenocarcinoma
(1 time)
|
General Surgery
(1 time)
|
---
|
2012 Histopathologic assessment of pancreatic cancer: does one size fit all?
|
| 22 |
pancreatoduodenectomy and the pancreatic adenocarcinoma
(1 time)
|
Neoplasms
(1 time)
|
Apaf-1 (1 time)
|
2020 Epigenetic Regulation of APAF-1 Through DNA Methylation in Pancreatic Cancer.
|
| 23 |
parenchyma and ductal adenocarcinomas
(1 time)
|
Radiology
(1 time)
|
CECT (2 times)
CCC (1 time)
|
2019 Radiomic feature reproducibility in contrast-enhanced CT of the pancreas is affected by variabilities in scan parameters and manual segmentation.
|
| 24 |
path-dependent attenuation correction
(1 time)
|
Diagnostic Imaging
(1 time)
|
ED (1 time)
ES (1 time)
LV (1 time)
|
1986 Attenuation correction in echocardiography.
|
| 25 |
patient survival in both malignant exocrine and ductal adenocarcinomas
(1 time)
|
Medicine
(1 time)
|
HR (1 time)
|
2013 Somatic mutations in exocrine pancreatic tumors: association with patient survival.
|
| 26 |
patients diagnosed with pancreatic cancer
(1 time)
|
Neoplasms
(1 time)
|
---
|
2018 Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma.
|
| 27 |
patients suffering from a ductal adenocarcinoma of the pancreas
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2010 Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry.
|
| 28 |
patients with adenocarcinoma
(1 time)
|
Chemistry
(1 time)
|
DM (1 time)
FLIM (1 time)
STZ (1 time)
|
2022 Contrast-Free FLIM Reveals Metabolic Changes in Pathological Islets of Langerhans.
|
| 29 |
PC ductal adenocarcinomas
(1 time)
|
|
MMR (1 time)
NGS (1 time)
PARPi (1 time)
|
2022 OncoPan: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma.
|
| 30 |
PDA capsule
(1 time)
|
|
DOX (1 time)
PAI (1 time)
PDAP (1 time)
|
2017 Polydopamine Nanocapsule: A Theranostic Agent for Photoacoustic Imaging and Chemo-Photothermal Synergistic Therapy.
|
| 31 |
PDAC cocultured with PSC
(1 time)
|
Neoplasms
(1 time)
|
hPSC (1 time)
NFV (1 time)
|
2016 The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells.
|
| 32 |
PDAC-exosomes
(1 time)
|
Neoplasms
(1 time)
|
DDSs (1 time)
PC (1 time)
|
2022 Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma.
|
| 33 |
photonic digital-to-analog converter
(1 time)
|
Ophthalmology
(1 time)
|
ODQPSK (1 time)
|
2012 Novel 2N bit bipolar photonic digital-to-analog converter based on optical DQPSK modulation coupled with differential detection.
|
| 34 |
PMH and FH of pancreatic
(1 time)
|
General Surgery
(1 time)
|
FDR (1 time)
|
2017 Cancer history: A predictor of IPMN subtype and dysplastic status?
|
| 35 |
Podocalyxin overexpression associates with poor survival in pancreatic cancer
(1 time)
|
Natural Science Disciplines
(1 time)
|
---
|
2021 Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer.
|
| 36 |
polarization-switching digital-to-analog converter
(1 time)
|
Nuclear Medicine
(1 time)
|
---
|
2005 Polarization-switching D/A converter.
|
| 37 |
polyamine deacetylase
(1 time)
|
Biochemistry
(1 time)
|
HDACs (1 time)
|
2022 First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement.
|
| 38 |
poor survival,pancreatic ductal adenocarcinoma
(1 time)
|
General Surgery
(1 time)
|
TSR (1 time)
|
2020 [Overview of tumor stroma ratio in pancreatic ductal adenocarcinoma].
|
| 39 |
poorly differentiated pancreatic adenocarcinoma
(1 time)
|
Neoplasms
(1 time)
|
DEGs (1 time)
GEPIA (1 time)
PPI (1 time)
|
2021 Identification of Critical Pathways and Potential Key Genes in Poorly Differentiated Pancreatic Adenocarcinoma.
|
| 40 |
potentially resectable ductal adenocarcinoma
(1 time)
|
Gastroenterology
(1 time)
|
PTO (1 time)
|
2019 Patients' treatment preferences for potentially resectable tumors of the head of the pancreas.
|
| 41 |
pregnancy day assessment
(1 time)
|
Medicine
(1 time)
|
BP (1 time)
PE (1 time)
|
2015 Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment for the exclusion of gestational hypertension and pre-eclampsia: a retrospective study in a university affiliated maternity hospital.
|
| 42 |
present day average crustal ratios
(1 time)
|
Environmental Health
(1 time)
|
KML (1 time)
|
2010 A study of radionuclides, metals and stable lead isotope ratios in sediments and soils in the vicinity of natural U-mineralisation areas in the Northern Territory.
|
| 43 |
primary ductal adenocarcinoma of the pancreas
(1 time)
|
Cell Physiological Phenomena
(1 time)
|
PMRCC (1 time)
|
2013 Pancreatic metastases of renal clear cell carcinoma: a clinicopathological study of 11 cases with special emphasis on the usefulness of PAX2 and mesothelin for the distinction from primary ductal adenocarcinoma of the pancreas.
|
| 44 |
prognosis associated with pancreatic cancer
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2015 Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
|
| 45 |
propofol, an anesthesia drug, in suppressing pancreatic cancer
(1 time)
|
Pharmacology
(1 time)
|
ADAM8 (1 time)
|
2020 Propofol affects the growth and metastasis of pancreatic cancer via ADAM8.
|
| 46 |
prostatic duct adenocarcinoma
(1 time)
|
Clinical Laboratory Techniques
(1 time)
|
DE (1 time)
DP (1 time)
DSen (1 time)
|
2006 [Evaluation of the diagnostic significance of cytologic studies in pancreatic tumors].
|
| 47 |
psychodisadaptation conditions
(1 time)
|
Neurology
(1 time)
|
---
|
1989 [Classification and psychological prevention of pre-nosological forms of borderline conditions occurring in the Northern Siberia].
|
| 48 |
Psychopharmacologic Drug Advisory Committee
(1 time)
|
Evidence-Based Medicine
(1 time)
|
COIs (1 time)
FDA (1 time)
|
2020 Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugs.
|
| 49 |
Pulmonary hypoplasia-diaphragmatic hernia-anophthalmia-cardiac defect
(1 time)
|
Genetics, Medical
(1 time)
|
STRA6 (1 time)
|
2009 Pulmonary hypoplasia-diaphragmatic hernia-anophthalmia-cardiac defect (PDAC) syndrome due to STRA6 mutations--what are the minimal criteria?
|
| 50 |
pulmonary hypoplasia/agenesis, diaphragmatic hernia/eventration, anophthalmia/microphthalmia, and cardiac defect
(1 time)
|
Clinical Medicine
(1 time)
|
---
|
2019 Microphthalmia Syndrome 9: Case Report of a Newborn Baby with Pulmonary Hypoplasia, Diaphragmatic Eventration, Microphthalmia, Cardiac Defect and Severe Primary Pulmonary Hypertension.
|
| 51 |
type, ductal adenocarcinoma
(1 time)
|
Molecular Biology
(1 time)
|
CI (1 time)
COX-2 (1 time)
IKK2 (1 time)
|
2016 Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53.
|
A Search Service for Abbreviation / Long Form